Publications

15 Aug 2024
Blog Post

Learning from Mistakes and Leveraging Personal Experiences: Tiffany Kent (MBA 2001)

Learn about the career resources available to HBS alumni through HBS Career & Professional Development I graduated from Harvard Business School at the tail end of the dot-com bubble and was fortunate to join Goldman Sach’s high-tech... View Details

Christian Kaps

Christian Kaps is an Assistant Professor of business administration in the Technology and Operations Management (TOM) Unit at Harvard Business School. Kaps' research focuses on emerging topics in renewable electricity generation and storage - notably how new... View Details

May 2020 (Revised November 2021)
Supplement

Valuing Peloton

By: E. Scott Mayfield

Peloton Interactive, a well-known unicorn in the connected fitness space, had gone public with a market capitalization of over $8.0 billion. In the weeks following its public debut, Peloton’s stock price fell by over 25%. Taylor Knox, a stock analyst and enthusiastic... View Details

Keywords: Business Model; Disruptive Innovation; Risk and Uncertainty; Stocks; Price; Valuation; Entertainment and Recreation Industry

Article

R&D: A Small Contribution to Productivity Growth

By: Diego Comin

In this paper I evaluate the contribution of R&D investments to productivity growth. The basis for the analysis are the free entry condition and the fact that most R&D innovations are embodied. Free entry yields a relationship between the resources devoted to R&D and... View Details

Keywords: Research and Development; Investment; Interest Rates; Performance Productivity; Technological Innovation; Perspective; United States

Find at Harvard

Read Now

December 2016 (Revised December 2018)
Case

From Start-Up to Grown-Up Nation: The Future of the Israeli Innovation Ecosystem

By: Elie Ofek and Margot Eiran

In June 2016, Benjamin (Bibi) Netanyahu, Prime Minister of Israel, wrestled with how to sustain Israel’s strong innovation track record and the country’s reputation as the “startup nation.” Despite the economic miracle the country had wrought since its founding, he... View Details

January 2010 (Revised August 2011)
Case

Ganeden Biotech, Inc.

By: Robert C. Pozen, Dale Alan Winger and Matthew Kenneth Ahlers

The CEO of Ganeden Biotech, a small firm with several viable probiotic products but limited resources, must decide what markets to invest in and what intellectual property strategies will best serve its immediate and longer-term business interests. View Details

Keywords: Entrepreneurship; Investment; Intellectual Property; Market Entry and Exit; Business Strategy; Biotechnology Industry

Allison Mnookin is a Senior Lecturer of Business Administration in the Technology and Operations Management (TOM) Unit at the Harvard Business School. She currently is the co-chair of the first-year MBA Technology and Operations Management course. In addition, she... View Details

June 2023 (Revised September 2023)
Simulation

Managing the Customer Journey Marketing Simulation: Adobe's Data-Driven Operating Model (DDOM)

By: Sunil Gupta, Rajiv Lal and Celine Chammas

Adobe started monitoring Annual Recurring Revenue (ARR), one of its primary metrics, when it shifted from selling its software in a box to selling the software as a subscription-based cloud service. They wanted to know when, where, and how much to invest in marketing.... View Details

Keywords: Customer Acquisition; Customer Journey; Marketing Strategy; Marketing; Customer Focus and Relationships; Budgets and Budgeting

April 2023
Case

Elliott Management: Capital Allocation in Biopharma

By: Amitabh Chandra, Paul Clancy and Lauren Gunasti

The case explores the intersection of capital allocation and shareholder activism in the biopharmaceutical industry. As many biopharma companies face looming patent expirations for key medicines, the case asks the question of whether investing in R&D and M&A is an... View Details

Keywords: Finance; Strategy; Capital Allocation; Biopharmaceutical Industry; Shareholder Activism; Investment Activism; Resource Allocation; Research and Development; Business and Shareholder Relations; Corporate Strategy; Pharmaceutical Industry

13 Jan 2017
News

Fidelity funds high on hot startups

David Ager

David Ager is a Senior Lecturer in Executive Education. He engages CEOs, CHROs, and their teams to design and deliver customized executive development experiences for executive, senior and high potential leaders. The companies hail from diverse sectors including... View Details

12 Mar 2020
Video

Muhammad Alagil

Muhammed Alagil, Chairman of Jarir Investment in Saudi Arabia, discusses how he and his brothers started the business with a small office supply store in 1979.

View Details

2010
Book

Winning in Emerging Markets: A Road Map for Strategy and Execution

By: Tarun Khanna, Krishna G. Palepu and Richard Bullock

The best way to select emerging markets to exploit is to evaluate their size or growth potential, right? Not according to Krishna Palepu and Tarun Khanna. In 'Winning in Emerging Markets,' these leading scholars on the subject present a decidedly different framework... View Details

Keywords: Developing Countries and Economies; Management Analysis, Tools, and Techniques; Emerging Markets; Organizations; Opportunities; Business Strategy

Find at Harvard

December 2022 (Revised May 2023)
Case

Iberdrola: Leading the Energy Revolution

By: Juan Alcácer and Emer Moloney

At the end of 2019, Ignacio Galán, the Chairman and CEO of the world's third largest utility, Iberdrola, reflected on his almost 20 years at the company. He managed a portfolio of three very different businesses, each with their own specific opportunities and... View Details

July 1993
Case

Genzyme Corporation: A Financing History

By: Timothy A. Luehrman and Andrew D. Regan

Genzyme Corp.'s financing history is unusual compared to most biotech companies. This case presents the sequence of financings employed by Genzyme, along with the product--market and corporate-development strategies adopted by Henri Termeer, Genzyme's CEO. As such, the... View Details

Keywords: History; Marketing Strategy; Financing and Loans; Business Strategy; Growth and Development Strategy; Biotechnology Industry

01 Apr 2022
Video

Professor Regina Herzliner: Innovating

December 2004 (Revised July 2005)
Case

Extend Fertility

By: Myra M. Hart and Sylvia Sensiper

Focuses on the search for opportunity, the generation and evaluation of business concepts, creation of a business plan, and the start-up process. Follows experienced entrepreneur Christy Jones as she combines her business skills and personal experience to generate new... View Details

Keywords: Opportunities; Business Plan; Entrepreneurship; Personal Development and Career; Social Issues; Gender; Business Startups; Biotechnology Industry